Cargando…
A Placebo‐Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease
BACKGROUND: Movement Disorder Society–Unified Parkinson's Rating Scale Part III (MDS‐UPDRS III) is the gold standard for assessing medication effects in patients with Parkinson's disease (PD). However, short and rater‐independent measurements would be ideal for future trials. OBJECTIVES: T...
Autores principales: | Thijssen, Eva, Makai‐Bölöni, Soma, van Brummelen, Emilie, den Heijer, Jonas, Yavuz, Yalcin, Doll, Robert‐Jan, Groeneveld, Geert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631850/ https://www.ncbi.nlm.nih.gov/pubmed/36339295 http://dx.doi.org/10.1002/mdc3.13563 |
Ejemplares similares
-
Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance
por: Makai-Bölöni, Soma, et al.
Publicado: (2021) -
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning
Off
of AZ‐009
por: Thijssen, Eva, et al.
Publicado: (2022) -
A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Na(v)1.8 inhibitor, in healthy adults
por: Hijma, Hemme J., et al.
Publicado: (2021) -
Experience in Genetic Counseling for GBA1 Variants in Parkinson's Disease
por: den Heijer, Jonas M., et al.
Publicado: (2020) -
Quantification of tremor using consumer product accelerometry is feasible in patients with essential tremor and Parkinson’s disease: a comparative study
por: van Brummelen, Emilie M. J., et al.
Publicado: (2020)